Does BEVACIZUMAB-MALY Cause Mucosal inflammation? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Mucosal inflammation have been filed in association with BEVACIZUMAB-MALY (ALYMSYS). This represents 5.8% of all adverse event reports for BEVACIZUMAB-MALY.
7
Reports of Mucosal inflammation with BEVACIZUMAB-MALY
5.8%
of all BEVACIZUMAB-MALY reports
0
Deaths
0
Hospitalizations
How Dangerous Is Mucosal inflammation From BEVACIZUMAB-MALY?
Of the 7 reports.
Is Mucosal inflammation Listed in the Official Label?
Yes, Mucosal inflammation is listed as a known adverse reaction in the official FDA drug label for BEVACIZUMAB-MALY.
What Other Side Effects Does BEVACIZUMAB-MALY Cause?
Asthenia (13)
Neutropenia (11)
Nausea (9)
Death (8)
Decreased appetite (8)
Aspartate aminotransferase increased (6)
Blood alkaline phosphatase increased (6)
Gamma-glutamyltransferase increased (6)
Thrombocytopenia (6)
Glaucoma (5)
What Other Drugs Cause Mucosal inflammation?
METHOTREXATE (3,352)
CYCLOPHOSPHAMIDE (2,535)
DOXORUBICIN (1,939)
VINCRISTINE (1,594)
ETOPOSIDE (1,591)
FLUOROURACIL (1,481)
RITUXIMAB (1,364)
CYTARABINE (1,337)
CAPECITABINE (1,262)
CARBOPLATIN (1,259)
Which BEVACIZUMAB-MALY Alternatives Have Lower Mucosal inflammation Risk?
BEVACIZUMAB-MALY vs BEXAROTENE
BEVACIZUMAB-MALY vs BEZAFIBRATE
BEVACIZUMAB-MALY vs BEZLOTOXUMAB
BEVACIZUMAB-MALY vs BGB-11417
BEVACIZUMAB-MALY vs BICALUTAMIDE